53
BIBLIOGRAFIA
1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 29 (2001):
1303-10.
2. Robert M. Berne, Matthew N. Levy, Bruce M. Koeppen, Bruce A.
Stanton, FISIOLOGIA, Zanichelli edizioni, quarta edizione.
3. G. Van den Berghe, F. de Zegher, R. Bouillon, Acute and prolonged critical illness as different neuroendocrine paradigms, J. Clin. Endocr.
Metab. 83 (1998): 1827-1834.
4. G. Van den Berghe, Dynamic neuroendocrine responses to critical illness, Frontiers in Neuroendocrinology 23 (2002): 370-391.
5. Scott C. Gibson, David A. Hartman, Jason M. Schenck, The endocrine response to critical illness: update and implications for emergency medicine, Emerg. Med. Clin N Am 23 (2005): 909-929.
6. Ilse Vanhorebeek and Greet Van den Berghe, Hormonal and metabolic strategies to attenuate catabolism in critically ill patients, Current Opinion in Pharmacology 4 (2004): 621-628.
54
7. Lies Langouche, Greet Van den Berghe, The dynamic neuroendocrine response to critical illness, Endocrinol. Metab. Clin. N Am 35 (2006) : 777- 791.
8. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003): 359–66.
9. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 27 (1987): 262-6.
10. Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C: Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 35 (1991): 47-54.
11. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996): 974-7.
12. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P,Gouwy S., Stockman W., Weekers F., Schetz M, Lauwers P., Bouillon R.,Bowers C.Y. ,Thyrotropin and prolactin release in prolonged critical illness:
55
dynamics of spontaneous secretion and effects of growth hormone- secretagogues, Clin. Endocrinol. (Oxf.) 47 (1997): 599-612.
13. Jensen MB, Kissmeyer-Nielsen P & Laurberg S. Perioperative growth hormone treatment increases nitrogen balance and results in short-term and long-term conservation of lean tissue mass. American Journal of Clinical Nutrition 68 (1998): 840-846.
14. Frustaci A, Perrone GA, Gentiloni N et al. Reversible dilated cardiomyopathy due to growth hormone deficiency. American Journal of Clinical Pathology 97 (1992): 503-511.
15. Takala J, Ruokonen E, Webster NR et al. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 1999; 341: 785-792.
16. E. Fliers, S.E. Guldenaar, W.M. Wiersinga, D.F. Swaab, Decreased hypotalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness, J. Clin. Endocrinol. Metab. 82 (1997): 4032- 4036.
17. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 41 (1994):
731– 7.
56
18. Faglia G, Ferrari C, Beck-Peccoz P, Spada A, Travaglini P, Ambrosi B.
Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects. Horm Metab Res 5 (1973): 289 – 92.
19. Stathatos N., Levetan C, Burman KD, et al. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab 15 (2001): 465-78.
20. Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M, et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 83 (1998): 309-19.
21. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 56 (2002): 655-669.
22. Brent GA, Hershman JM. Thyroxine therapy in patients with severe non thyroidal illness and low serum thyroxine concentration. J Clin Endocrinol Metab 63 (1986): 1 - 8.
57
23. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ,et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333 (1995): 1522 - 7.
24. Vermes I, Beishuizen A. The hypothalamic–pituitary–adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 15 (2001): 495–
511.
25. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients:
possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80 (1995): 1238– 42.
26. Beishuizen A, Thijs LG, Vermes I, Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma.
Intensive Care Med 27 (2001): 1584-91.
27. LN Parker, ER Levin, ET Lifrak, Evidence for adrenocortical adaptation to severe illness, J. Clin. Endocrinol. Metab. 60 (1985): 947- 952.
28. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 42 (1997): 27– 31.
58
29. Koo DJ, Jackman D, Chaudry IH, Wang P. Adrenal insufficiency during the late stage of polymicrobial sepsis. Crit Care Med 29 (2001):
618–22.
30. RD Zipser, MW Davenport, KL Martin, ML Tuck, NE Warner, RR Swinney, CL Davis, R Horton, Hyperreninemic hypoaldosteronism in the criticall ill: a new entity, J. Clin. Endocrinol. Metab. 53 (1981): 867-873.
31. Beishuizen A, Lamberthus GT, Istvan V, Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Critical Care (2006): 434-438.
32. Dh Russell, New aspects of prolactin and immunity: a lymphocyte- derived prolactin-like product and nuclear protein kinase C activation, Trends Pharmacol. Sci. 10 (1989): 40-44.
33. Van den Berghe G, de Zegher F, Lauwers P,et al. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine.
Clin. Endocrinol. Metab. (Oxf.) 41 (1994): 563-9.
34. Van den Berghe G, Weekwers F, Baxter RC, et al., Five day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitaty-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J. Clin.
Endocrinol. Metab. 86 (2001): 3217-26.
59
35. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, et al., Increase in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Phisiol Endocrinol Metab 291, (2006): E631-E638.
36. Luppa P, Munker R, Nagel D, Weber M, Engelhardt D, serum androgens in intensive-care patients correlations with clinical findings, Clinical Endocrinology 34 (4); (1991): 305-310.
37. Spratt DI. Altered gonadal steroidogenesis in critical illness: is treatment with anabolic steroids indicated? Best Practice and Research Clinical Endocrinology and Metabolism 15 (4); (2001): 479-494.
38. Ferrando AA, Sheffield-moore M., Wolf SE., Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med. 29 (2001): 1936-1942.
39. Demling RH, Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 25 (1999): 215-221.
40. Paul L. Marino, The ICU Book. Terapia Intensiva. Principi fondamentali; (2007), Ediz. Elsevier.
60
41. Dossett LA, Swenson BR, Heffernan D, Bonatti H, Metzger R, Sawyer RG, May AK. High levels of endogenous estrogens are associated with death in the critically injured adult. J Trauma 64(3); (2008) Mar: 580-5.
42. Christeff N, Auclair MC, Thobie N, Fertil B, Carli A, Nunez EA. Effect of estradiol on endotoxin-induced changes in steroid hormone levels and lethality in male rats. Circ. Shock. 44 (1994): 154-159.
43. Knoferl MW, Angele MK, Diodato MD, et al.: Female sex hormones regulate macrophage function after trauma-hemorrage and prevent increased death rate from subsequent sepsis. Ann Surg 235 (2002): 105- 112.
44. Wichmann MW, Inthorn D, Andress HJ, et al.: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive care med 26 (2000):
167-172.
45. May AK, Dossett LA, Norris PR, Hansen EN, Dorsett RC, Popovsky KRN, Sawyer RG, Estradiol is associated with mortality in critically ill and surgical patients, Crit Care Med 36 (2008): 62-68.
46. Angstwurm MWA, Gaertner R, Schopohl J: Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med 33 (2005): 2786-2793.
